X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2657) 2657
Magazine Article (9) 9
Dissertation (6) 6
Book Chapter (4) 4
Book / eBook (3) 3
Web Resource (3) 3
Streaming Video (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2577) 2577
hiv infections - drug therapy (1990) 1990
anti-retroviral agents - therapeutic use (1686) 1686
female (1556) 1556
male (1455) 1455
adult (1292) 1292
hiv (1272) 1272
anti-retroviral agents - adverse effects (1223) 1223
middle aged (896) 896
infectious diseases (868) 868
antiretroviral therapy (852) 852
human immunodeficiency virus--hiv (759) 759
hiv infections - complications (628) 628
antiviral agents (618) 618
hiv infection (583) 583
risk factors (562) 562
drug therapy (532) 532
immunology (502) 502
aids (500) 500
antiretroviral drugs (495) 495
highly active antiretroviral therapy (483) 483
anti-retroviral agents - administration & dosage (457) 457
health aspects (398) 398
acquired immune deficiency syndrome--aids (387) 387
therapy (382) 382
treatment outcome (381) 381
cd4 lymphocyte count (378) 378
hiv infections - epidemiology (344) 344
human-immunodeficiency-virus (330) 330
research (321) 321
viral load (319) 319
young adult (312) 312
hiv patients (311) 311
medicine, general & internal (303) 303
adolescent (301) 301
care and treatment (300) 300
antiretroviral agents (286) 286
mortality (285) 285
pregnancy (279) 279
prevalence (269) 269
pharmacology & pharmacy (255) 255
virology (252) 252
human immunodeficiency virus (248) 248
public, environmental & occupational health (248) 248
aids/hiv (247) 247
aged (244) 244
hiv-1 (239) 239
hiv infections - virology (229) 229
drug therapy, combination (228) 228
risk (228) 228
analysis (227) 227
prospective studies (216) 216
retrospective studies (216) 216
hiv/aids (211) 211
cohort studies (208) 208
cross-sectional studies (208) 208
active antiretroviral therapy (207) 207
medicine (207) 207
research article (206) 206
prevention (202) 202
antiretroviral therapy, highly active - adverse effects (200) 200
patients (200) 200
protease inhibitors (200) 200
medicine & public health (199) 199
abridged index medicus (198) 198
drug interactions (198) 198
infection (197) 197
microbiology (194) 194
hiv infections - immunology (193) 193
infections (192) 192
infected patients (187) 187
child (186) 186
adherence (185) 185
hiv infections - prevention & control (180) 180
hiv-infected patients (179) 179
dosage and administration (175) 175
complications and side effects (173) 173
adults (172) 172
antiretroviral therapy, highly active (172) 172
drugs (168) 168
anti-retroviral agents - pharmacology (167) 167
tuberculosis (167) 167
virus diseases (166) 166
hiv infections - psychology (158) 158
hiv infections - transmission (158) 158
medication adherence (157) 157
risk-factors (157) 157
public health (152) 152
acquired immune deficiency syndrome (150) 150
acquired immunodeficiency syndrome - drug therapy (149) 149
usage (149) 149
disease (148) 148
anti-hiv agents - therapeutic use (147) 147
infant (147) 147
infant, newborn (147) 147
children (146) 146
hiv infections - diagnosis (144) 144
cd4 antigen (143) 143
tenofovir (143) 143
animals (142) 142
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2598) 2598
Spanish (43) 43
French (38) 38
German (21) 21
Portuguese (20) 20
Dutch (4) 4
Japanese (4) 4
Chinese (3) 3
Russian (3) 3
Czech (2) 2
Danish (2) 2
Turkish (2) 2
Polish (1) 1
Serbian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Danel, Christine and Moh, Raoul and Gabillard, Delphine and Badje, Anani and Le Carrou, Jérôme and Ouassa, Timothée and Ouattara, Eric and Anzian, Amani and Ntakpé, Jean-Baptiste and Minga, Albert and Kouame, Gérard M and Bouhoussou, Franck and Emieme, Arlette and Kouamé, Antoine and Inwoley, André and Toni, Thomas-D'Aquin and Ahiboh, Hugues and Kabran, Mathieu and Rabe, Cyprien and Sidibé, Baba and Nzunetu, Gustave and Konan, Romuald and Gnokoro, Joachim and Gouesse, Patrice and Messou, Eugène and Dohoun, Lambert and Kamagate, Synali and Yao, Abo and Amon, Solange and Kouame, Amadou-Barenson and Koua, Aboli and Kouamé, Emmanuel and Ndri, Yao and Ba-Gomis, Olivier and Daligou, Marcelle and Ackoundzé, Simplice and Hawerlander, Denise and Ani, Alex and Dembéle, Fassery and Koné, Fatoumata and Guéhi, Calixte and Kanga, Constance and Koule, Serge and Séri, Jonas and Oyebi, Mykayila and Mbakop, Nathalie and Makaila, Olewole and Babatunde, Carole and Babatounde, Nathanael and Bleoué, Gisèle and Tchoutedjem, Mireille and Kouadio, Alain-Claude and Sena, Ghislaine and Yededji, Sahinou-Yediga and Assi, Rodrigue and Bakayoko, Alima and Mahassadi, Alassane and Attia, Alain and Oussou, Armel and Mobio, Max and Bamba, Doféré and Koman, Mesmin and Horo, Apollinaire and Deschamps, Nina and Chenal, Henri and Sassan-Morokro, Madeleine and Konate, Seidou and Aka, Kakou and Aoussi, Eba and Journot, Valérie and Nchot, Célestin and Karcher, Sophie and Chaix, Marie-Laure and Rouzioux, Christine and Sow, Papa-Salif and Perronne, Christian and Girard, Pierre-Marie and Menan, Hervé and Bissagnene, Emmanuel and Kadio, Auguste and Ettiegne-Traore, Virginie and Moh-Semdé, Corinne and Kouame, Abo and Massumbuko, Jean-Marie and Chêne, Geneviève and Dosso, Mireille and Domoua, Serge K and N'Dri-Yoman, Thérèse and Salamon, Roger and Eholié, Serge P and Anglaret, Xavier and The TEMPRANO ANRS 12136 Study Group and TEMPRANO ANRS 12136 Study Group
The New England journal of medicine, ISSN 1533-4406, 2015, Volume 373, Issue 9, pp. 808 - 822
Journal Article
CNS drugs, ISSN 1172-7047, 02/2014, Volume 28, Issue 2, pp. 131 - 145
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2015, Volume 372, Issue 6, pp. 509 - 518
Preventing HIV-1 infection is a high global priority. This study assessed prevention strategies in young women in South Africa, Uganda, and Zimbabwe using oral or vaginal antiretroviral agents... 
TRIALS | MEDICINE, GENERAL & INTERNAL | TRANSMISSION | ANTIRETROVIRAL PROPHYLAXIS | MICROBICIDE | PREVENTION | ADHERENCE | GEL | HIV Infections - prevention & control | Humans | Middle Aged | Drug Resistance, Viral | Administration, Intravaginal | Deoxycytidine - blood | Adenine - blood | Tenofovir | Young Adult | Adenine - adverse effects | Adult | Deoxycytidine - adverse effects | Female | Organophosphonates - blood | Surveys and Questionnaires | Anti-Retroviral Agents - blood | Drug Therapy, Combination | Emtricitabine | Adenine - analogs & derivatives | HIV Seropositivity | Administration, Oral | HIV-1 - drug effects | Deoxycytidine - administration & dosage | Anti-Retroviral Agents - adverse effects | Organophosphonates - adverse effects | Africa South of the Sahara | Adenine - administration & dosage | Pre-Exposure Prophylaxis | Organophosphonates - administration & dosage | Medication Adherence | Anti-Retroviral Agents - administration & dosage | Adolescent | HIV Infections - complications | Deoxycytidine - analogs & derivatives | Women | Care and treatment | HIV infection in women | Dosage and administration | HIV infection | Health aspects | Risk factors | Intervention | Creatinine | Antiretroviral drugs | Motivation | Human immunodeficiency virus--HIV | Prophylaxis | Vagina | Infections | Preventive medicine
Journal Article
BMJ Open, ISSN 2044-6055, 09/2017, Volume 7, Issue 9, p. e019022
...).DesignWe performed random effects meta-analysis for HIV-related outcomes and network meta-analysis for HBV outcomes, and used the Grading of Recommendations Assessment, Development and Evaluation (GRADE... 
chronic hepatitis B | network meta-analysis | tenofovir | HIV & AIDS | pregnancy | mother-to-child transmission | LAMIVUDINE | MEDICINE, GENERAL & INTERNAL | TENOFOVIR DISOPROXIL FUMARATE | INFECTED WOMEN | RANDOMIZED-TRIALS | EFFICACY | VIRUS INFECTION | SAFETY | PREVENT PERINATAL TRANSMISSION | TO-CHILD TRANSMISSION | PREEXPOSURE PROPHYLAXIS | Humans | Infant | Hepatitis B - complications | Lamivudine - adverse effects | Young Adult | Ritonavir - adverse effects | Lamivudine - therapeutic use | Ritonavir - therapeutic use | Adult | Female | Anti-Retroviral Agents - therapeutic use | Emtricitabine - adverse effects | Emtricitabine - therapeutic use | Tenofovir - adverse effects | Tenofovir - therapeutic use | Zidovudine - adverse effects | Anti-Retroviral Agents - adverse effects | Infectious Disease Transmission, Vertical | Pregnancy | HIV Infections - complications | Hepatitis B - drug therapy | Pregnancy Complications, Infectious - drug therapy | HIV Infections - drug therapy | Lopinavir - therapeutic use | Zidovudine - therapeutic use | Drug Combinations | Lopinavir - adverse effects | Pregnancy Outcome | Low income groups | Antiretroviral drugs | Keywords | Systematic review | Infections | Patients | Evidence-based medicine | Meta-analysis | Studies | Hepatitis | Acquired immune deficiency syndrome--AIDS | Hepatology | Human immunodeficiency virus--HIV | Medical Subject Headings-MeSH | Drug therapy
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2006, Volume 354, Issue 3, pp. 251 - 260
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2012, Volume 367, Issue 5, pp. 423 - 434
...–FTC group had a lower incidence of HIV infection but increased rates of side effects, including a significant loss of bone density... 
PREVENTION | TRIALS | MEDICINE, GENERAL & INTERNAL | TENOFOVIR DISOPROXIL FUMARATE | INFECTION | EMTRICITABINE | HIV Infections - prevention & control | Humans | Drug Resistance, Viral | Male | RNA, Viral - blood | Viral Load | Tenofovir | Young Adult | Deoxycytidine - therapeutic use | Adenine - adverse effects | Adenine - therapeutic use | HIV-1 - isolation & purification | Adult | Deoxycytidine - adverse effects | Female | HIV-2 - genetics | Contraception Behavior - statistics & numerical data | Drug Therapy, Combination | Emtricitabine | Anti-Retroviral Agents - therapeutic use | Adenine - analogs & derivatives | HIV Seropositivity | Organophosphonates - therapeutic use | HIV-2 - isolation & purification | Anti-Retroviral Agents - adverse effects | Kaplan-Meier Estimate | Organophosphonates - adverse effects | Proportional Hazards Models | Sexual Behavior - statistics & numerical data | HIV-1 - genetics | Bone Density - drug effects | Adolescent | Deoxycytidine - analogs & derivatives | Prevention | Drugs | Dose-response relationship (Biochemistry) | Control | Disease transmission | Dosage and administration | Product/Service Evaluations | Drug therapy | HIV infection | Medical research | Prophylaxis | Infections | Nausea | Disease control | Studies | Motivation | Antiretroviral agents | Vomiting | Human immunodeficiency virus--HIV | Bone mineral density
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2015, Volume 373, Issue 8, pp. 705 - 713
Among patients coinfected with HIV-1 and HCV genotype 1 or 4 who were receiving effective antiretroviral therapy, treatment with 12 weeks of ledipasvir and... 
MEDICINE, GENERAL & INTERNAL | HEPATOCELLULAR-CARCINOMA | INTERFERON | THERAPY | HEPATITIS-C VIRUS | CIRRHOSIS | ALPHA-2A PLUS RIBAVIRIN | VETERANS | GENOTYPE 1 INFECTION | COHORT | LIVER-DISEASE | HIV-1 | Humans | Middle Aged | Drug Resistance, Viral | Fluorenes - therapeutic use | Hepacivirus - genetics | Male | RNA, Viral - blood | Hepatitis C, Chronic - complications | Viral Load | Female | Fluorenes - adverse effects | Uridine Monophosphate - adverse effects | Benzimidazoles - adverse effects | Drug Therapy, Combination | Benzimidazoles - therapeutic use | Uridine Monophosphate - therapeutic use | Hepacivirus - drug effects | Fluorenes - pharmacokinetics | Hepacivirus - isolation & purification | Anti-Retroviral Agents - therapeutic use | Antiviral Agents - therapeutic use | Benzimidazoles - pharmacokinetics | Genotype | Hepatitis C, Chronic - drug therapy | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | HIV Infections - complications | HIV Infections - drug therapy | Uridine Monophosphate - pharmacokinetics | Sofosbuvir | Care and treatment | Research | Hepatitis C virus | HIV infection | Emtricitabine | Headache | Antiretroviral drugs | Inhibitor drugs | Diarrhea | Fatigue | Patients | Efavirenz | Studies | Tenofovir | Cirrhosis | Genotype & phenotype | Hepatitis | Human immunodeficiency virus--HIV | Hepatitis C | Drug therapy | Genotypes
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2012, Volume 366, Issue 25, pp. 2380 - 2389
Journal Article